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||ABSTRACT
Background: Alzheimer’s disease (AD) is one of the most common neurodegenerative syndromes characterized by a progressive
decline in the spatial memory. There are convincing evidences on the neuroprotective effects of ﬂavonoids against AD. Aims and
Objective: To determine the effect of quercetin on the acquisition and retention of spatial memory in a rat model of AD.
Materials and Methods: Twenty-four male Wistar rats were divided into four groups (six in each): group I: control rats
receiving intracerebroventricular (ICV) injection of normal saline, group II: rats induced AD by ICV injection of streptozotocin
(STZ; 3 mg/kg bilaterally; twice, on days 1 and 3), and groups III and IV: ICV-STZ AD rats treated intraperitoneally (IP) with
40 and 80 mg/kg/day quercetin, respectively, over a period of 12 days. Then, the rats were trained with four trials per day
for ﬁve consecutive days in the Morris water maze (MWM). On the sixth day, the memory retention was evaluated. Result: The
ICV-STZ AD groups showed a signiﬁcant impairment in the acquisition and retrieval of spatial memory when compared with
the control group (P o 0.001). In the AD groups, the escape latency during the training trials showed a signiﬁcant decrease
(Po 0.001). Meanwhile, during the MWM task, these rats spent more time in the target quadrant in probe trials when compared
with the controls. Conclusion: Quercetin acted as a spatial memory enhancer in ICV-STZ–induced AD rats. Hence, this ﬂavonoid
can be considered potentially as a promising agent for developing prophylactic and therapeutic neuroprotection. This
neuroprotective effect of quercetin may be attributed to its antioxidant and scavenging properties.
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||INTRODUCTION
Alzheimer’s disease (AD) is a complex neurodegenerative
syndrome characterized by a progressive decline in learning,
memory, and other cognitive capabilities.[1] The two relevant
major pathological events of AD are: forming the senile
plaques, consisting, predominantly, of extracellular amyloid-b
(Ab) peptides, and neuroﬁbrillary tangles, including polymer-
ized hyperphosphorylated tau protein.[2] Sporadic Alzheimer’s
disease (SAD) constitutesB99% of all the AD cases, and it is a
multifactorial disease caused by genetic, environmental, and
metabolic factors.[2,3]
The ICV-STZ–induced AD is a valid experimental model for
researchers to evaluate the new treatments for AD.[4,5] To date,
it has been reported that various compounds inhibit the
formation and extension of Ab ﬁbrils and destabilizing Ab
ﬁbrils in vitro. Polyphenolic compounds have been extensively
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studied and have shown to exhibit strong anti-Ab ﬁbrils aggregation
effects.[6] Polyphenolic compounds are extensively distributed in
fruits and vegetables. Quercetin (3,30,40,5,7-pentahydroxyﬂavone) is
one of the most abundant bioﬂavonoids, which represent more than
60% of the average polyphenol ingestion.[7,8] Quercetin acts as an
excellent free radical scavenger and antioxidant. Among its many
well-studied health beneﬁcial effects such as neuroprotection,[9,10]
anticancer,[11,12] and hepatoprotective effects,[13,14] it has been
shown that quercetin also possesses attenuated spatial learning and
memory impairment in d-galactose–treated mice, suggesting its
potential antiaging effect.[15] Moreover, one previous study reported
the protective effect of long-term treatment with quercetin on
cognition in a mouse model of AD.[16] To our knowledge, there are
no reports on the inﬂuence of quercetin against ICV-STZ–induced
cognitive dysfunction in the rat. The effect of quercetin administra-
tion on the spatial memory in ICV-STZ AD rats is not well
understood to date. Therefore, this study was performed to evaluate
the effect of quercetin on the spatial memory in a rat model of
ICV-STZ–induced sporadic AD.
||MATERIALS AND METHODS
Quercetin was purchased from Sigma–Aldrich. Then, it was
suspended in 1 mL of 1% ethanol diluted with sterile saline.
STZ of analytical grade (Sigma–Aldrich, USA) was dissolved in
cold normal saline. Healthy adult male Wistar rats, weighing
250–300 g, were obtained from the Experiment Animal Center
of Golestan Medical Sciences University, Gorgan, Iran. All of the
animal experiments were performed according to the guidelines
of the National Institutes of Health and Animal Ethics
Committee of Golestan University of Medical Sciences. The rats
were maintained in a 12-h light–dark cycle at a controlled
temperature (22 ± 1°C) with food and water ad libitum.
Animals were anesthetized with an intraperitoneally (IP)
injection of ketamine (80 mg/kg) and xylazine (2.5 mg/kg) and,
then, surgery was performed according to the previously described
protocol using a stereotaxic (Stoelting, USA) apparatus. The
coordinates of the ICV cannula implantation were 0.8 mm anterior
to posterior (AP) bregma, 1.8 mm midline to lateral (ML), and
4 mm dorsal to ventral (DV) dura.[16] STZ dissolved in normal
saline was infused bilaterally into the cerebroventricles (5 mL on
each site and the ﬁnal concentration of 3 mg/kg body weight)
through microinjection pump, which was connected to a Hamilton
microsyringe.[4,17] One minute after infusion, the needle was
removed slowly from the site. The same administration of STZ was
repeated 48 h after the ﬁrst infusion. The solutions were freshly
prepared just before the injection to avoid their decomposition. The
same volume of sterile saline was infused as the vehicle control.
The rats were divided randomly into the following four
groups (n = 6 each):
group I: control normal saline-injected group, included
normal healthy rats that received intracerebroventricular (ICV)
injection of normal saline (5 mL/site/rat).
group II: STZ group, included rats with induced AD by ICV
injection of STZ as mentioned earlier.
group III: STZ+Qu40, rats in this group received quercetin
in a daily dose of 80 mg/kg IP[18] for 12 consecutive days,
followed by 1 week after induction of AD by ICV injection of
STZ.
group IV: STZ+Qu 80, rats in this group received quercetin
in a daily dose of 100 mg/kg IP[18] for 12 days, followed by
1 week after induction of AD, as previously mentioned.
Morris Water Maze
The Morris water maze (MWM) task was done according to a
protocol described elsewhere.[18] The water maze consisted of a
swimming pool that was adapted for rats. It consisted of a circular
tank (150 cm diameter, 60 cm high), ﬁlled to a depth of 50 cm with
water maintained at 26°C. Located inside the pool was a
removable, circular platform made of Plexiglas, positioned such
that its top surface was 0.5 cm below the water. Data were
collected using a video camera ﬁxed to the ceiling of the room and
connected to a video recorder and to a video-tracking system
(Maze router, Urmia, Iran), both located in an adjacent room, which
housed the home cages of the rats undergoing testing. The
swimming pathway and initial latency in locating the hidden
escape platform were recorded for each trial.
For 5 consecutive days, on each day, the rats were subjected
to one session of four trials. A trial terminated when the animal
reached the platform, where it was allowed to remain for 15 s.
On the sixth day, following 24 h after the last training session,
the retention of the spatial memory was assessed with a 60-s
probe trial; each rat was randomly released at any one of the
starting points (N–S–E–W), facing the wall of the pool with the
removed platform. The parameters measured on the probe trial
were the time spent in the target quadrant and the initial
latency to ﬁnd the escape platform. All the behavioral tests were
conducted at the same time of the day (8:00 a.m. to 4:00 p.m.).
The timeline of experiments is shown in Figure 1.
Statistical Analysis
The results are presented as mean ± SEM and analyzed using
SPSS software, version 17.0. All the data were analyzed by the
one-way analysis of variance and Student’s t-test. Po 0.05 was
considered statistically signiﬁcant.
||RESULT
Figure 2 shows the time taken to reach the hidden platform (A)
and swim path (B) on each training day for ICV-STZ–induced AD
and control groups. The mean escape latency for the trained rats
was decreased over the course of the 20 learning trials in both the
groups. The control group rats (vehicle treated) exhibited
signiﬁcantly lower escape latency in all days during the training
trials when compared with the AD group (Po 0.01). The two-way
repeated measurement of ANOVA test revealed that ICV-STZ model
signiﬁcantly increased escape latency when compared with the
control group rats on days 1–5 (P o 0.001). As shown in
Figure 2B, there was a signiﬁcant difference in swimming path
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lengths to reach the platform among the control and SAD groups
(P o 0.01 and P o 0.001).
The mean latencies and swim path lengths in both the
groups suggest that their motor performance (ability to swim)
was unaffected by the stereotaxic surgery, whereas the ICV-STZ
group tended to use more time than the controls in the
following trials. ICV-STZ–induced AD animals showed a lower
ability to ﬁnd the platform and learn its location in all the 5 days
of training. Furthermore, statistical analysis revealed that ICV-
STZ–induced AD rats showed longer escape latencies and swim
path length than controls during the all 5 days of training trials.
Figure 3 shows the time taken to reach the hidden platform
on each training day among the quercetin-treated and control
groups. The MWM performance task data indicated that
quercetin in both doses (40 and180 mg/kg) signiﬁcantly
attenuate escape latency (P o 0.001) in SAD model of rats
when compared with control group on days 1–5. No signiﬁcant
differences were observed among the quercetin-treated groups.
For all the days, the quercetin-treated animals showed a
signiﬁcant difference in the escape latency, suggesting that
quercetin groups performed signiﬁcantly better than the
controls over time.
The swimming speed during the acquisition test for
representative animals in each group are shown in Figure 4.
There were no signiﬁcant difference changes among the four
groups from the mean swimming speed between the days
during the study, indicating that all of the groups revealed
similar motor capabilities. From this, we assumed that the rats
were able to swim acceptably.
The probe trial data of the MWM study on the last day
(sixth) showed that the average time spent in target quadrant,
where the hidden platform was previously placed, signiﬁcantly
increased with quercetin treatment when compared with SAD
nontreated group [Figure 5]. It was further observed that the
ICV-STZ group signiﬁcantly impaired the memory retention, and
the target quadrant preference diminished signiﬁcantly in SAD
animals model (Po 0.05). The treatment with quercetin in both
the doses signiﬁcantly prevented the memory impairment as
indicated by the increase in the time spent in the target
quadrant (P o 0.01). The data from the probe trial test
Figure 2: Comparison of escape latency (A) and traveled swimming distance path (B) during training trial days. The ﬁgures show that the escape
latency and traveled distance signiﬁcantly increased in SAD model group rats at all the 5 days of training compared with the control group (**po 0.01,
***p o 0.001, respectively). Data expressed as mean ± SEM of six rats in each groups.
Figure 3: Comparison of escape latency during the training days. The
ﬁgure shows the escape latency for control, SAD-nontreated, and SAD+
Qu–treated (80 mg/kg and 100 mg/kg) groups. Values are mean ±
SEM. n = 6 in each groups. ***p o 0.001 in two-way repeat-measured
ANOVA.
Figure 1: Timelines of experiments.
Figure 4: Comparison of swimming speed during the training days.
The ﬁgures show the escape for control, SAD-nontreated, and SAD +
Qu–treated (80 mg/kg and 100 mg/kg) groups. Values are mean ±
SEM. n = 6 in each group. There were no signiﬁcant differences in
swimming speed between the different groups.
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indicated that quercetin treatment signiﬁcantly improved
the memory deﬁcits seen in SAD model rats, and both the
quercetin-treated groups showed a clear preference for the
former platform quadrant (ANOVA, P o 0.01). There were no
signiﬁcant differences in the time spent in the platform
quadrant between the quercetin groups.
||DISCUSSION
Our results showed that ICV injection of STZ deteriorates spatial
learning and memory. We found that the escape latency and
swim path to ﬁnd a hidden platform in MWM signiﬁcantly
increased in all 5 days of trials in ICV-STZ treated rats, and the
time spent in the platform quadrant signiﬁcantly decreased
at the sixth day in ICV-STZ–treated rats, which conﬁrmed the
STZ-induced memory deﬁcits. Quercetin treatment with two
doses caused a signiﬁcant decrease in escape latency during the
training days when compared with the control group. Moreover,
quercetin-treated animals found the hidden platform sooner
than the ICV-STZ AD group in the probe trial. These data
provide evidences that quercetin improved spatial learning and
memory capabilities both in the acquisition and retention of
spatial memory in the MWM performance task. Previous report
has shown that quercetin treatment (5–20 mg/kg, po, twice
daily, 30 days) in STZ-induced diabetic rats prevented the
changes in MWM performance.[19] Furthermore, Mohammadi
et al.[20] also showed that quercetin (50 mg/kg) treatment
during restraint stress (21 days) signiﬁcantly decreased escape
latency and increased the time spent in target quadrant during
water maze task.
It has been shown that vitamin D[21,22] and ﬂavonoids[20]
are involved in brain function and some of behavioral aspects of
neurocognition. On the basis of literature, the positive effects of
quercetin on cognition may be attributed to a variety of its
biological effects.
Quercetin is considered as an excellent free radical
scavenger and possesses strong antioxidant properties.[23,24]
The antioxidant and anti-inﬂammatory properties of querce-
tin have been associated with its ameliorating effect against
cellular oxidative stress[25] and related diseases. Thus, it is
possible that quercetin creates a good environment in CNS
because of its antioxidant capacity. On the other hand, similar
to the beneﬁcial effects of traditional antioxidant nutrients,
quercetin inhibits the production of NO as dose-dependent
manner[26] that serves to protect the brain from free radicals-
induced damage. The other possibility is that, although it is
generally agreed that quercetin is a proapoptotic agent,[26]
but owing to its antioxidant and scavenging effects, which
might suggest a different function for it as antiapoptotic
activity, the issue will need to be investigated further. In this
study, quercetin might have protected ICV-STZ–induced
AD-associated cognitive dysfunction by reducing oxidative
stress. It might be concluded that quercetin may be able to
stimulate hippocampal cells regeneration in a rat model of
ICV-STZ–induced AD.
One potential mechanism for the memory-enhancing effect
of quercetin may be related with its interaction to membrane
receptors. It is plausible that quercetin may interact with
transmembrane protein-bound receptors such as adrenergic
and glutamatergic receptors. Accordingly, it has been shown
that the quercetin may be involved in negative modulation of
NMDA receptors and can inhibit these receptors.[27] Moreover,
the chemical structure of quercetin is similar to the mammalian
estrogen. As an estrogen receptor regulator, quercetin has a
high afﬁnity to estrogen receptor binding points.[28,29] However,
this mechanism needs to be elucidated, and it would be of interest
to further investigate to clarify the quercetin mechanisms of
memory enhancing.
||CONCLUSION
In summary, our study demonstrates that quercetin, the
widespread consumed dietary ﬂavonoid, can improve brain
cognitive function and, thus, may potentially exert a useful
effect for memory and learning disturbance caused by
ICV-STZ–induced rat model of sporadic AD, which could be
related to its free radical-scavenging effects, antioxidant
activity, and possibly interaction to membrane-bound recep-
tors. However, the exact mechanism of these effects remains
to be elucidated.
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